These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 21196926)

  • 1. Expression of Ki-67, p53 and vascular endothelial growth factor (VEGF) concomitantly in growth hormone-secreting pituitary adenomas; which one has a role in tumor behavior ?
    Yarman S; Kurtulmus N; Canbolat A; Bayindir C; Bilgic B; Ince N
    Neuro Endocrinol Lett; 2010; 31(6):823-8. PubMed ID: 21196926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunohistochemistry for pituitary hormones and Ki-67 in growth hormone producing pituitary adenomas].
    Brito J; Sáez L; Lemp M; Liberman C; Michelsen H; Araya AV
    Rev Med Chil; 2008 Jul; 136(7):831-6. PubMed ID: 18949157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevation of growth hormone secretagogue receptor type 1a mRNA expression in human growth hormone-secreting pituitary adenoma harboring G protein alpha subunit mutation.
    Xu T; Ye F; Wang B; Tian C; Wang S; Shu K; Guo D; Lei T
    Neuro Endocrinol Lett; 2010; 31(1):147-54. PubMed ID: 20150876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Markers of function and proliferation in non-invasive and invasive bi- and plurihormonal adenomas of patients with acromegaly: an immunohistochemical study.
    Müller W; Saeger W; Wellhausen L; Derwahl KM; Hamacher C; Lüdecke DK
    Pathol Res Pract; 1999; 195(9):595-603. PubMed ID: 10507079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical tumor growth and comparison with proliferation markers in non-functioning (inactive) pituitary adenomas.
    Saeger W; Lüdecke B; Lüdecke DK
    Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):80-5. PubMed ID: 18072009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low aryl hydrocarbon receptor-interacting protein expression is a better marker of invasiveness in somatotropinomas than Ki-67 and p53.
    Kasuki Jomori de Pinho L; Vieira Neto L; Armondi Wildemberg LE; Gasparetto EL; Marcondes J; de Almeida Nunes B; Takiya CM; Gadelha MR
    Neuroendocrinology; 2011; 94(1):39-48. PubMed ID: 21178332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions.
    Thapar K; Scheithauer BW; Kovacs K; Pernicone PJ; Laws ER
    Neurosurgery; 1996 Apr; 38(4):765-70; discussion 770-1. PubMed ID: 8692397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective analysis of 151 cases of patients with acromegaly operated by one neurosurgeon: a follow-up of more than 23 years.
    Abbassioun K; Amirjamshidi M; Mehrazin A; Khalatbary I; Keynama M; Bokai H; Abdollahi M
    Surg Neurol; 2006 Jul; 66(1):26-31; discussion 31. PubMed ID: 16793431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical analysis of tumor angiogenic factors in human pituitary adenomas.
    Niveiro M; Aranda FI; Peiró G; Alenda C; Picó A
    Hum Pathol; 2005 Oct; 36(10):1090-5. PubMed ID: 16226108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexpression of vascular endothelial growth factor and p53 protein in squamous cell carcinoma of the esophagus.
    Koide N; Nishio A; Hiraguri M; Hanazaki K; Adachi W; Amano J
    Am J Gastroenterol; 2001 Jun; 96(6):1733-40. PubMed ID: 11419822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An analysis of granulation patterns, MIB-1 proliferation indices and p53 expression in 101 patients with acromegaly.
    Sarkar S; Chacko AG; Chacko G
    Acta Neurochir (Wien); 2014 Dec; 156(12):2221-30; discussion 2230. PubMed ID: 25238988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of p53, Bcl-2, VEGF, Ki67 and PCNA and prognostic significance in hepatocellular carcinoma.
    Stroescu C; Dragnea A; Ivanov B; Pechianu C; Herlea V; Sgarbura O; Popescu A; Popescu I
    J Gastrointestin Liver Dis; 2008 Dec; 17(4):411-7. PubMed ID: 19104702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acromegaly].
    Katakami H
    Nihon Rinsho; 2006 May; Suppl 1():129-38. PubMed ID: 16776111
    [No Abstract]   [Full Text] [Related]  

  • 14. Expression of vascular endothelial growth factor in salivary gland carcinomas and its relation to p53, Ki-67 and prognosis.
    Lim JJ; Kang S; Lee MR; Pai HK; Yoon HJ; Lee JI; Hong SP; Lim CY
    J Oral Pathol Med; 2003 Oct; 32(9):552-61. PubMed ID: 12969230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical relevance of proliferation biomarkers and p53 expression in rectal mucosa and sporadic colonic adenomas: a prospective study.
    Freitas D; Goulão MH; Camacho E; Figueiredo P; Ministro P; Ferreira M; Portela F; Andrade P; Donato A; Martins MI
    Hepatogastroenterology; 2002; 49(47):1269-74. PubMed ID: 12239922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathobiology of pituitary adenomas and carcinomas.
    Scheithauer BW; Gaffey TA; Lloyd RV; Sebo TJ; Kovacs KT; Horvath E; Yapicier O; Young WF; Meyer FB; Kuroki T; Riehle DL; Laws ER
    Neurosurgery; 2006 Aug; 59(2):341-53; discussion 341-53. PubMed ID: 16883174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of vascular endothelial growth factor and receptor flk-1 in colon cancer liver metastases.
    Cheng J; Slavin RE; Gallagher JA; Zhu G; Biehl TR; Swanstrom LL; Hansen PD
    J Hepatobiliary Pancreat Surg; 2004; 11(3):164-70. PubMed ID: 15235888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 protein expression in intraductal papillary mucinous tumors (IPMT) of the pancreas as an indicator of tumor malignancy.
    Kawahira H; Kobayashi S; Kaneko K; Asano T; Ochiai T
    Hepatogastroenterology; 2000; 47(34):973-7. PubMed ID: 11020860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD147 expression in pituitary adenomas and its significance for clinical outcome.
    Qu X; Yang W; Jiang M; Han T; Han L; Qu Y; Wang G; Shi D; Xu G
    Hum Pathol; 2010 Aug; 41(8):1165-71. PubMed ID: 20381119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of somatostatin analogues on Ki-67 levels in GH-secreting adenomas.
    Selek A; Cetinarslan B; Canturk Z; Tarkun I; Hanazay Y; Vural C; Anik I; Ceylan S
    Growth Horm IGF Res; 2019 Apr; 45():1-5. PubMed ID: 30731342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.